Human TRPV4 channel splice variants revealed a key role of ankyrin domains in multimerization and trafficking.
The TRPV4 cation channel exhibits a topology consisting of six predicted transmembrane domains (TM) with a putative pore loop between TM5 and TM6 and intracellular N- and C-tails, the former containing at least three ankyrin domains. Functional transient receptor potential (TRP) channels are supposed to result following the assembly of four subunits. However, the rules governing subunit assembly and protein domains implied in this process are only starting to emerge. The ankyrin, TM, and the C-tail domains have been identified as important determinants of the oligomerization process. We now describe the maturation and oligomerization of five splice variants of the TRPV4 channel. The already known TRPV4-A and TRPV4-B (delta384-444) variants and the new TRPV4-C (delta237-284), TRPV4-D (delta27-61), and TRPV4-E (delta237-284 and delta384-444) variants. All alternative spliced variants involved deletions in the cytoplasmic N-terminal region, affecting (except for TRPV4-D) the ankyrin domains. Subcellular localization, fluorescence resonance energy transfer, co-immunoprecipitation, glycosylation profile, and functional analysis of these variants permitted us to group them into two classes: group I (TRPV4-A and TRPV4-D) and group II (TRPV4-B, TRPV4-C, and TRPV4-E). Group I, unlike group II variants, were correctly processed, homo- and heteromultimerized in the endoplasmic reticulum, and were targeted to the plasma membrane where they responded to typical TRPV4 stimuli. Our results suggest that: 1) TRPV4 biogenesis involves core glycosylation and oligomerization in the endoplasmic reticulum followed by transfer to the Golgi apparatus for subsequent maturation; 2) ankyrin domains are necessary for oligomerization of TRPV4; and 3) lack of TRPV4 oligomerization determines its accumulation in the endoplasmic reticulum.
Arniges
Maite
M
Grup de Canalopaties, Unitat de Senyalització Cellular, Universitat Pompeu Fabra, C/Dr. Aiguader 80, 08003 Barcelona, Spain.
Fernández-Fernández
José M
JM
Albrecht
Nadine
N
Schaefer
Michael
M
Valverde
Miguel A
MA
D017398:Alternative Splicing; D017487:Ankyrins / Q000378:metabolism; D001483:Base Sequence; D001665:Binding Sites; D002460:Cell Line; D003001:Cloning, Molecular; D017931:DNA Primers; D004721:Endoplasmic Reticulum / Q000378:metabolism; D006031:Glycosylation; D006801:Humans; D007473:Ion Channels / Q000502:physiology; D007668:Kidney; D016297:Mutagenesis, Site-Directed; D011994:Recombinant Proteins / Q000378:metabolism; D020545:Respiratory Mucosa / Q000502:physiology; D017384:Sequence Deletion; D050916:TRPV Cation Channels / Q000235:genetics* / Q000378:metabolism
D017487:Ankyrins; D017931:DNA Primers; D007473:Ion Channels; D011994:Recombinant Proteins; D050916:TRPV Cation Channels; C416986:TRPV4 protein, human